Evidence map›Paper›PMID 24625757›Full record

ArticlePloS one2014

HPV E6/E7 RNA in situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade.

Mark F Evans, Zhihua Peng, Kelli M Clark, Christine S-C Adamson, Xiao-Jun Ma, Xingyong Wu, Hongwei Wang, Yuling Luo, Kumarasen Cooper

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Localization and genotyping of canine papillomavirus in canine inverted papillomas.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior.International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists · 2020
    Article
  16. Article
  17. Clinicopathologic Association and Prognostic Value of MELF Pattern in Invasive Endocervical Adenocarcinoma (ECA) as Classified by IECC.International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists · 2020
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mark F EvansDepartment of Pathology, University of Vermont, Burlington, Vermont, United States of America.
Zhihua PengDepartment of Pathology, University of Vermont, Burlington, Vermont, United States of America.
Kelli M ClarkDepartment of Pathology, University of Vermont, Burlington, Vermont, United States of America; Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care, Burlington, Vermont, United States of America.
Christine S-C AdamsonDepartment of Pathology, University of Vermont, Burlington, Vermont, United States of America.
Xiao-Jun MaAdvanced Cell Diagnostics, Inc., Hayward, California, United States of America.
Xingyong WuAdvanced Cell Diagnostics, Inc., Hayward, California, United States of America.
Hongwei WangAdvanced Cell Diagnostics, Inc., Hayward, California, United States of America.
Yuling LuoAdvanced Cell Diagnostics, Inc., Hayward, California, United States of America.
Kumarasen CooperDepartment of Pathology, University of Vermont, Burlington, Vermont, United States of America; Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care, Burlington, Vermont, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical lesion grading is critical for effective patient management. A three-tier classification (cervical intraepithelial neoplasia [CIN] grade 1, 2 or 3) based on H&E slide review is widely used. However, for reasons of considerable inter-observer variation in CIN grade assignment and for want of a biomarker validating a three-fold stratification, CAP-ASCCP LAST consensus guidelines recommend a two-tier system: low- or high-grade squamous intraepithelial lesions (LSIL or HSIL). In this study, high-risk HPV E6/E7 and p16 mRNA expression patterns in eighty-six CIN lesions were investigated by RNAscope chromogenic in situ hybridization (CISH). Specimens were also screened by immunohistochemistry for p16INK4a (clone E6H4), and by tyramide-based CISH for HPV DNA. HPV genotyping was performed by GP5+/6+ PCR combined with cycle-sequencing. Abundant high-risk HPV RNA CISH signals were detected in 26/32 (81.3%) CIN 1, 22/22 (100%) CIN 2 and in 32/32 (100%) CIN 3 lesions. CIN 1 staining patterns were typified (67.7% specimens) by abundant diffusely staining nuclei in the upper epithelial layers; CIN 2 lesions mostly (66.7%) showed a combination of superficial diffuse-stained nuclei and multiple dot-like nuclear and cytoplasmic signals throughout the epithelium; CIN 3 lesions were characterized (87.5%) by multiple dot-like nuclear and cytoplasmic signals throughout the epithelial thickness and absence/scarcity of diffusely staining nuclei (trend across CIN grades: P<0.0001). These data are consistent with productive phase HPV infections exemplifying CIN 1, transformative phase infections CIN 3, whereas CIN 2 shows both productive and transformative phase elements. Three-tier data correlation was not found for the other assays examined. The dual discernment of diffuse and/or dot-like signals together with the assay's high sensitivity for HPV support the use of HPV E6/E7 RNA CISH as an adjunct test for deciding lesion grade when CIN 2 grading may be beneficial (e.g. among young women) or when 'LSIL vs. HSIL' assignment is equivocal.

Indexed as

AdolescentAdultBiomarkersCohort StudiesCyclin-Dependent Kinase Inhibitor p16Disease ProgressionDNA-Binding ProteinsFemaleGenes, ViralGenotypeHumansIn Situ HybridizationMiddle AgedOncogene Proteins, ViralPapillomaviridaePapillomavirus InfectionsBiomarkersCyclin-Dependent Kinase Inhibitor p16DNA-Binding ProteinsE6 protein, Human papillomavirus type 18E7 protein, Human papillomavirus type 18Oncogene Proteins, ViralRNA, Viral

Identifiers

PMID24625757
PMCPMC3953338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.